117 related articles for article (PubMed ID: 38460446)
21. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
22. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
23. EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study.
Zhuang CL; Shen X; Zou HB; Dong QT; Cai HY; Chen XL; Yu Z; Wang SL
Clin Nutr; 2020 Jul; 39(7):2301-2310. PubMed ID: 31732287
[TBL] [Abstract][Full Text] [Related]
24. Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study.
Dong QT; Cai HY; Zhang Z; Zou HB; Dong WX; Wang WB; Song HN; Luo X; Chen XL; Huang DD
Clin Nutr; 2021 May; 40(5):3360-3369. PubMed ID: 33223117
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
26. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.
Shi B; Liu S; Chen J; Liu J; Luo Y; Long L; Lan Q; Zhang Y
Ann Nutr Metab; 2019; 75(4):213-222. PubMed ID: 31846973
[TBL] [Abstract][Full Text] [Related]
28. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
Şahin MEH; Akbaş F; Yardimci AH; Şahin E
BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
[TBL] [Abstract][Full Text] [Related]
29. Impact of skeletal muscle mass in patients with recurrent gastric cancer.
Matsunaga T; Satio H; Miyauchi W; Shishido Y; Miyatani K; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
World J Surg Oncol; 2021 Jun; 19(1):170. PubMed ID: 34116681
[TBL] [Abstract][Full Text] [Related]
30. Preoperative skeletal muscle index vs the controlling nutritional status score: Which is a better objective predictor of long-term survival for gastric cancer patients after radical gastrectomy?
Zheng ZF; Lu J; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Cancer Med; 2018 Aug; 7(8):3537-3547. PubMed ID: 29953752
[TBL] [Abstract][Full Text] [Related]
31. Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer: a comprehensive analysis of two-center study.
Han Y; Wu J; Ji R; Tan H; Tian S; Yin J; Xu J; Chen X; Liu W; Cui H
BMC Cancer; 2023 Aug; 23(1):751. PubMed ID: 37580693
[TBL] [Abstract][Full Text] [Related]
32. Adverse Effects of Low Preoperative Skeletal Muscle Mass in Patients Undergoing Gastrectomy for Gastric Cancer.
Sakurai K; Kubo N; Tamura T; Toyokawa T; Amano R; Tanaka H; Muguruma K; Yashiro M; Maeda K; Hirakawa K; Ohira M
Ann Surg Oncol; 2017 Sep; 24(9):2712-2719. PubMed ID: 28477088
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis.
Lee JK; Park YS; Lee K; Youn SI; Won Y; Min SH; Ahn SH; Park DJ; Kim HH
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1897-1907. PubMed ID: 34533290
[TBL] [Abstract][Full Text] [Related]
34. Body mass index and mortality in patients with gastric cancer: a large cohort study.
Lee JH; Park B; Joo J; Kook MC; Kim YI; Lee JY; Kim CG; Choi IJ; Eom BW; Yoon HM; Ryu KW; Kim YW; Cho SJ
Gastric Cancer; 2018 Nov; 21(6):913-924. PubMed ID: 29651648
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.
Zhang Y; Wang JP; Wang XL; Tian H; Gao TT; Tang LM; Tian F; Wang JW; Zheng HJ; Zhang L; Gao XJ; Li GL; Wang XY
Curr Oncol; 2018 Oct; 25(5):e411-e422. PubMed ID: 30464692
[TBL] [Abstract][Full Text] [Related]
36. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy.
Rier HN; Jager A; Sleijfer S; van Rosmalen J; Kock MCJM; Levin MD
Breast; 2017 Feb; 31():9-15. PubMed ID: 27810702
[TBL] [Abstract][Full Text] [Related]
37. Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Fujimoto Y; Iida T; Yagi S; Taura K; Hatano E; Okajima H; Uemoto S
Ann Surg Oncol; 2017 Apr; 24(4):1037-1045. PubMed ID: 27837297
[TBL] [Abstract][Full Text] [Related]
38. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
39. Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy.
Aichi M; Hasegawa S; Kurita Y; Shinoda S; Kato S; Mizushima T; Yokota NR; Miyagi E
Nutrition; 2023 May; 109():111966. PubMed ID: 36731243
[TBL] [Abstract][Full Text] [Related]
40. Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer.
Park SE; Choi JH; Park JY; Kim BJ; Kim JG; Kim JW; Park JM; Chi KC; Hwang IG
Sci Rep; 2020 Oct; 10(1):17683. PubMed ID: 33077864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
